Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease

被引:0
|
作者
Marie Monsinjon
Diane Mege
Léon Maggiori
Xavier Treton
Yoram Bouhnik
Yves Panis
机构
[1] Beaujon Hospital,Department of Colorectal Surgery
[2] Assistance Publique-Hôpitaux de Paris,Department of Gastroenterology
[3] Université Paris VII,undefined
[4] Beaujon Hospital,undefined
[5] Assistance Publique-Hôpitaux de Paris,undefined
[6] Université Paris VII,undefined
[7] Service de Chirurgie Colorectale,undefined
[8] Pôle des Maladies de L’Appareil Digestif (PMAD),undefined
[9] Hôpital Beaujon,undefined
关键词
Severe acute colitis; Inflammatory bowel disease; Biological therapy; Medical treatment; Subtotal colectomy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1499 / 1502
页数:3
相关论文
共 50 条
  • [31] The Influence of Anti-TNF Therapy on the Course of Chronic Hepatitis C Virus Infection in Patients with Inflammatory Bowel Disease
    Lin, Ming Valerie
    Blonski, Wojciech
    Buchner, Anna M.
    Reddy, K. Rajender
    Lichtenstein, Gary R.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (04) : 1149 - 1156
  • [32] The Influence of Anti-TNF Therapy on the Course of Chronic Hepatitis C Virus Infection in Patients with Inflammatory Bowel Disease
    Ming Valerie Lin
    Wojciech Blonski
    Anna M. Buchner
    K. Rajender Reddy
    Gary R. Lichtenstein
    Digestive Diseases and Sciences, 2013, 58 : 1149 - 1156
  • [33] Inflammatory and cancerous skin lesions in inflammatory bowel disease patients treated with anti-TNF therapy
    Ocepek, A.
    Drobez, C. Pernat
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S252 - S253
  • [34] ANTI-TNF INDUCED LYMPHOCYTOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Soufleris, Konstantinos
    Kafalis, Nikolaos
    Fasoulas, Konstantinos
    Pilpilidis, Ioannis
    Lazaraki, Georgia
    Markala, Dimitra
    Tzilves, Dimitris
    GASTROENTEROLOGY, 2019, 156 (06) : S635 - S635
  • [35] Anti-TNF induced lupus in patients with inflammatory bowel disease
    Picardo, S.
    So, K.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 109 - 109
  • [36] Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
    Dahmus, Jessica
    Rosario, Michelle
    Clarke, Kofi
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 339 - 350
  • [37] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Andreou, N. P.
    Gazouli, M.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I354 - I355
  • [38] Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
    Abreu, Candida
    Afonso, Joana
    Dias, Claudia Camila
    Ruas, Rogerio
    Sarmento, Antonio
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1223 - 1229
  • [39] EXCESSIVE WEIGHT GAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ON ANTI-TNF THERAPY
    Mitchel, Elana
    Huang, Jing
    Zemel, Babette
    Baldassano, Robert N.
    Albenberg, Lindsey
    Denburg, Michelle
    GASTROENTEROLOGY, 2021, 160 (06) : S527 - S528
  • [40] Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    De, Tanima
    Zhang, Honghong
    Alarcon, Cristina
    Lec, Bianca
    Avitia, Juan
    Smithberger, Erin
    Chen, Chuyu
    Horvath, Minnie
    Kwan, Sara
    Young, Mary
    Adhikari, Sarbani
    Kwon, John
    Pacheco, Jennifer
    Jarvik, Gail
    Wei, Wei-Qi
    Mentch, Frank
    Hakonarson, Hakon
    Sleiman, Patrick
    Gordon, Adam
    Harley, John
    Linneman, Jim
    Hebbring, Scott
    Parisiadou, Loukia
    Perera, Minoli A.
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (01): : 1 - 9